logo

For the Inventor, By the Inventor

Ann Arbor, MI, United States of America

Sham Shridhar Nikam

This inventor holds 26 USPTO granted patents, primarily in Neuropharmacology. Top assignees: Warner-Lambert Company, Warner Lambert LLC, Other. Active years: 1996-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sham Shridhar Nikam. Retrieved from https://idiyas.com/inventor/sham-shridhar-nikam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26

% Patents Active = 69.2

Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:

goldMedal24 out of 2,538 
 
Warner-Lambert Company
 patents
silverMedal1 out of 22 
 
Warner Lambert LLC
 patents
bronzeMedal1 out of 834,513 
Other
 patents

Years Active: 1996-2006

Loading Chart...
Areas of Expertise:
Piperazine Derivatives
Cyclohexylamine
NMDA Receptor Antagonists
Quinoxaline
Glutamate Receptor
Neuroprotective Agents
Sulfonamide Derivatives
Cyclic Amine Derivatives
Endothelin Converting Enzyme
Chiral Ethyl
Amide Derivatives
Tricyclic Quinazolines
26 patents (USPTO):Explore Patents
1. 7101886 - Phenylalkyl and pyridylalkyl piperazine derivatives (2006-09-05),
2. 6919377 - Cyclohexylamine derivative as subtype selective NMDA receptor antagonists (2005-07-19),
3. 6828341 - Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists (2004-12-07),
4. 6794402 - Bicyclic cyclohexylamines and their use as NMDA receptor antagonists (2004-09-21),
5. 6765022 - Cyclohexylamine derivatives as subtype selective nmda receptor antagonists (2004-07-20),
6. 6683101 - Bicyclic cyclohexylamines and their use as NMDA receptor antagonists (2004-01-27),
7. 6642256 - Piperidine derivatives as subtype selective N-Methyl-D-Aspartate antagonists (2003-11-04),
8. 6455698 - Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents (2002-09-24),
9. 6417396 - Quenching reagents for solution phase synthesis (2002-07-09),
10. 6395930 - Quenching reagents for solution phase synthesis (2002-05-28),
11. 6340758 - Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents (2002-01-22),
12. 6268366 - Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists (2001-07-31),
13. 6191134 - Amide derivatives of substituted quinoxaline 2, 3-diones as glutamate receptor antagonists (2001-02-20),
14. 6172065 - Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists (2001-01-09),
15. 6121488 - Quenching reagents for solution phase synthesis (2000-09-19),

Title: The Innovative Journey of Sham Shridhar Nikam

Introduction: Sham Shridhar Nikam, a talented inventor based in Ann Arbor, MI, is known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sham Shridhar Nikam holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing her commitment to creating a more sustainable future.

Career Highlights: With a background in engineering and a passion for problem-solving, Sham Shridhar Nikam has had a successful career marked by numerous achievements in the development of cutting-edge technologies.

Collaborations: Throughout her career, Sham Shridhar Nikam has collaborated with leading research institutions, universities, and tech companies to bring her innovative ideas to life, further solidifying her reputation as a visionary inventor.

Conclusion: Sham Shridhar Nikam's dedication to innovation and her relentless pursuit of technological advancement continue to inspire the next generation of inventors and pave the way for a brighter, more sustainable future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…